Latest news

Clinical update-Debio-9902 SR (ZT-1) implant for Alzheimer´s disease-First patients enroll in Phase II “BRAINz” study

Debiopharm and EPFL Establish An Oncology Chair

Debiopharm signs Canadian Partner for Sanvar®

Clinical Update – Decapeptyl®/Trelstar® 6-Month Formulation in Advanced Prostate Cancer

Debiopharm favorise l’Esprit d’Entreprise en Valais

Chinese Scientist Receives the Debiopharm-CCRF China Award

Ipsen and Debiopharm extend their Agreement for the Exclusive Commercialization of Decapeptyl®

Debiopharm and Nanocarrier sign License and Supply Agreement for DACH-Platin Polymeric Micelle in Oncology

Japanese Scientists Receive JCA-Mauvernay Award 2007